What ACIST does

ACIST Medical Systems, founded in 1991 by Dr. Robert F. (Bob) Wilson and headquartered in Eden Prairie, Minnesota, designs and manufactures cardiovascular diagnostic imaging and physiological assessment technologies used in catheterization laboratories. Its product portfolio is organized around three clinical workflows: angiography/contrast management (ACIST CVi and the next-generation ACIST Pro), intravascular imaging (ACIST HDi with Kodama HD IVUS catheter and HubVue PACS integration), and physiology (ACIST RXi and RXi Mini systems with Navvus II microcatheters and the ACIST dPR non-hyperemic pressure ratio algorithm). The platforms are designed to reduce contrast-induced acute kidney injury, improve IVUS-guided PCI optimization, and enable physiology-based coronary assessment without adenosine-induced hyperemia.

ACIST operates as a wholly-owned subsidiary of Bracco Group, an Italian diagnostic imaging company that acquired ACIST in 2001; SVMI and the HDi IVUS technology were acquired by ACIST in 2012 to extend the portfolio beyond contrast injection. The business generates revenue through three streams: capital medical equipment sales (contrast injectors, IVUS consoles, FFR consoles) priced by quote, recurring consumable catheter revenue from Navvus II and Kodama disposable devices used per procedure, and multi-year service and support contracts offering preventive maintenance, loaner equipment, and on-site technical assistance. Distribution combines direct field sales in the Americas, EMEA (Netherlands headquarters), and APAC (Japan) with a multi-region distributor network covering more than 60 countries.

The company's go-to-market is anchored by enterprise sales targeting cath labs and cardiovascular departments in hospitals, supported by clinical education (webinars, KOL-led content, conference presence at TCT, ACC, ML CTO, and Scripps CV Interventions) and a medical education grant program. ACIST received U.S. FDA 510(k) clearance for ACIST Pro in May 2026 and CE Mark approval under the European MDR in February 2026, following an initial 2025 launch in Japan, and operates with ISO 13485, ISO 45001, and ISO 14001 certifications. Bracco Group reports approximately €1.29 billion in consolidated revenue across its full portfolio; ACIST-specific revenue is not separately disclosed.

Name

ACIST

Legal name

ACIST Medical Systems, Inc.

Website

https://acist.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

ACIST Medical Systems, a Bracco Group subsidiary founded in 1991, manufactures cardiovascular diagnostic technologies — contrast injection, IVUS imaging, and FFR/dPR physiology systems — for hospitals, cath labs, and interventional cardiologists across more than 60 countries.

Ownership category

akta.pro rank

Product category

Interventional Cardiology Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Contrast Media Injectors & Radiology Accessories (HLAHABAK)

akta.pro secondary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Contrast injection systems
• Intravascular ultrasound imaging
• Fractional flow reserve
• Interventional cardiology devices
• Cardiac catheterization equipment

Headquarters

HQ city

Eden Prairie

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of capital medical equipment including contrast injection systems (ACIST CVi, ACIST Pro), IVUS imaging systems (ACIST HDi), and FFR measurement systems (ACIST RXi, ACIST RXi Mini) to hospitals and cath labs.
2. Consumable Catheters: Recurring revenue from disposable microcatheters including Navvus® II and Kodama® IVUS catheters used during procedures.
3. Service and Support Contracts: Technical support services including on-site assistance within 24 hours, next-day service loaner equipment, preventive maintenance and upgrades, offered as multi-year service packages.
4. Technical Support Services: Customer service and technical support provided to European customers with on-site assistance and service loaner programs.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

ACIST Medical Systems manufactures and sells cardiovascular diagnostic and interventional devices, including contrast injection systems (ACIST CVi and ACIST Pro), intravascular ultrasound imaging systems (ACIST HDi with Kodama catheters), and fractional flow reserve measurement systems (ACIST RXi with Navvus II microcatheters). These products are sold as capital equipment and disposable consumables to hospitals, cardiac catheterization laboratories, and interventional cardiologists for use in diagnostic and interventional cardiology, peripheral vascular, and structural heart procedures.

Product overview

ACIST Medical Systems, a Bracco Group company, provides a portfolio of diagnostic technologies for cardiovascular and peripheral vascular procedures. The product ecosystem centers on contrast management (ACIST Pro™, ACIST CVi®), intravascular imaging (ACIST HDi® with Kodama® catheter), and physiological assessment (ACIST RXi® with Navvus® II microcatheter and dPR feature). Products serve diagnostic and interventional cardiology, radiology, and vascular care across angiography, imaging, and physiology categories. The company operates from headquarters in Eden Prairie, Minnesota with European operations in the Netherlands and offices in Japan and Silicon Valley.

Differentiator

Problem solved

Functional benefit

Brands

• ACIST CVi: Contrast Delivery System for managing contrast delivery and minimizing risk of contrast-induced acute kidney injury (CI-AKI) in interventional cardiology procedures.
• ACIST HDi
• ACIST RXi
• ACIST RXi Mini
• Navvus II
• Kodama
• ACIST Pro
• ACIST dPR

Products and services

• ACIST Pro Diagnostic System Next-generation variable-rate contrast management solution for image-guided cardiovascular procedures that builds on ACIST CVi technology to deliver automated contrast delivery with reduced contrast use and improved patient outcomes; for interventional cardiologists and cath lab teams.
• ACIST CVi Contrast Delivery System Contrast Delivery System providing real-time, variable-flow control of contrast for precise and consistent contrast administration with built-in air column detection sensor alerts; for interventional cardiologists managing contrast volume and minimizing risk of contrast-induced acute kidney injury (CI-AKI).
• ACIST HDi High-Definition IVUS System 60MHz high-definition intravascular ultrasound imaging system enabling optimized visualization for coronary and peripheral intervention strategy through three imaging modes (LumenView, SilkView, ClassicView) and an interactive compact console; for interventional cardiologists performing PCI optimization.
• ACIST RXi Rapid Exchange FFR System Rapid Exchange Fractional Flow Reserve system with dPR (Diastolic Pressure Ratio) for physiological assessment of coronary disease using a monorail microcatheter and 0.014 inch guidewire of choice; for interventional cardiologists assessing coronary stenosis severity.
• ACIST RXi Mini System Next-generation compact FFR measurement system engineered to integrate with hemodynamic systems and FFR software; for cath labs seeking simplified physiological assessment workflow.
• Navvus II Rapid Exchange FFR MicroCatheter Rapid Exchange FFR MicroCatheter with improved flexibility, reduced lesion entry profile, and 0.014 inch guidewire compatibility for navigation of complex coronary artery disease; used with ACIST RXi system for physiological assessment.
• Kodama HD IVUS Catheter HD IVUS Catheter with offset distal tip and VariFlex variable flexibility imaging window providing improved deliverability and optimized imaging for both coronary and peripheral vascular procedures; used with ACIST HDi console with 10x faster pullback at 10mm/sec.
• ACIST Service and Support Contracts Multi-year technical support service packages including on-site assistance within 24 hours, next-day service loaner equipment, preventive maintenance, and upgrades for ACIST capital equipment installed in cath labs.

Quantifiable outcome

• 45ml average reduction in contrast use
• +10 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Bracco GroupcoreStrategic or Co-development PartnerACIST Medical Systems is a wholly-owned subsidiary of Bracco Group, a Milan-based international healthcare company and world leader in diagnostic imaging. Bracco Imaging S.p.A. acquired ACIST in 2001. Bracco Group has approximately 3,420 employees and annual consolidated revenues of around 1.29 billion euros with 86% from international sales.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• HeartFlow: HeartFlow provides non-invasive FFR-CT analysis as an alternative to catheter-based FFR measurement, targeting the same clinical decision point as ACIST's RXi/dPR platform but with a fundamentally different (imaging-based) delivery model.
• CathWorks: CathWorks offers FFR-angio (cath lab-based non-invasive FFR) as a catheter-free alternative to traditional FFR measurement, representing emerging competitive pressure on ACIST's catheter-based physiology franchise.

Broad incumbents

• GE HealthCare: GE HealthCare offers contrast media injectors (OptiStar, EmpowerCTA) and broad imaging/IT infrastructure for cath labs and interventional suites, overlapping with ACIST's contrast management and PACS integration offerings at a much larger scale.
• Philips: Philips owns Volcano (IVUS/FFR) and offers Azurion interventional suites with integrated imaging and contrast injection, competing with ACIST across both the capital equipment and physiology/imaging consumables in the cath lab.
• Bayer (Medrad): Medrad (Bayer) is one of the largest manufacturers of contrast media injectors (Mark 7 Arterion) and interventional radiology equipment, competing head-to-head with ACIST's CVi/Pro in hospitals and imaging centers worldwide.
• Siemens Healthineers: Siemens Healthineers provides Artis interventional angiography systems, contrast injectors, and broad imaging IT that overlaps with ACIST's offerings in hospital cath lab and interventional radiology environments.

Direct peers

• Boston Scientific: Boston Scientific competes directly with ACIST in intravascular imaging through its OptiCross IVUS and AVVIGO guidance system, serving the same interventional cardiology cath lab customers with overlapping procedure-driven utilization.
• Opsens (Haemonetics): Opsens (acquired by Haemonetics) provides the OptoWire FFR measurement system, directly competing with ACIST's RXi/Navvus platform in catheter-based physiological assessment of coronary artery disease.
• Guerbet: Guerbet is a leading contrast media and contrast injection systems manufacturer, directly competing with ACIST's CVi and Pro contrast management systems in hospital radiology and cardiology departments globally.
• Abbott: Abbott competes with ACIST through its PressureWire FFR/iwFR physiology platform and OPTIS IVUS/OCT imaging systems, serving the same interventional cardiology procedure workflow with comparable catheter-based diagnostic offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/acist_medical
• YouTubeyoutube.com/channel/UClz317sX14tan8HgWQ67Z1Q
• Facebookfacebook.com/ACISTMedicalSystemsInc
• LinkedInlinkedin.com/company/acist-medical-systems
• Instagraminstagram.com/acistmedical/?hl=en

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACIST